| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Gastrointestinal and Liver Physiology, Vol 263, Issue 3 327-G332, Copyright © 1992 by American Physiological Society
ARTICLES |
L. Lu and C. D. Logsdon
Department of Physiology, University of Michigan, Ann Arbor 48109-0622.
To identify possible nuclear signals mediating long-term regulation of the pancreas by gastrointestinal hormones, the expression of c-fos, c-jun, and c-myc was investigated in rat pancreatic acini. Stimulation of the acini with cholecystokinin octapeptide (CCK-8, 100 pM), bombesin (10 nM), or carbachol (10 microM), but not gastrin (100 nM), secretin (100 nM), or vasoactive intestinal peptide (10 nM) induced an increase in oncogene mRNA expression. The percent increases of c-fos, c-jun, and c-myc mRNA were 207 +/- 40, 171 +/- 26, and 46 +/- 19 (n = 5) for CCK-8; 223 +/- 71, 159 +/- 31, and 43 +/- 21 (n = 5) for bombesin; and 125 +/- 51, 123 +/- 58, and 67 +/- 19 (n = 5) for carbachol, respectively. CCK-induced increases in oncogene mRNA were rapid and transient. c-fos and c-jun mRNA levels were increased after 30 min stimulation, peaked at 1 h, and returned to basal level in 2 h. Activation of c-myc was more prolonged with levels remaining elevated for at least 3 h. The effects of CCK-8 were concentration dependent. Detectable stimulation was seen at 10 pM; maximal stimulation occurred at 10 nM and was not affected by further increase in the concentration of CCK-8. JMV-180, a high-affinity site CCK receptor agonist and low-affinity site antagonist, alone did not stimulate c-fos mRNA expression but inhibited c-fos mRNA expression induced by CCK-8. These results suggest that the interaction between CCK and the low-affinity state of the CCK receptor is responsible for oncogene activation.
This article has been cited by other articles:
|
|
 |
|
  M. D. Baumler, D. W. Nelson, D. M. Ney, and G. E. Groblewski Loss of exocrine pancreatic stimulation during parenteral feeding suppresses digestive enzyme expression and induces Hsp70 expression Am J Physiol Gastrointest Liver Physiol, March 1, 2007; 292(3): G857 - G866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Guo, M. D. Sans, G. T. Gurda, S.-H. Lee, S. A. Ernst, and J. A. Williams Induction of early response genes in trypsin inhibitor-induced pancreatic growth Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G667 - G677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G M Ledda-Columbano, A Perra, M Pibiri, F Molotzu, and A Columbano Induction of pancreatic acinar cell proliferation by thyroid hormone J. Endocrinol., June 1, 2005; 185(3): 393 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ji, X.-q. Chen, D. E. Misek, R. Kuick, S. Hanash, S. Ernst, R. Najarian, and C. D. Logsdon Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator Physiol Genomics, June 24, 2003; 14(1): 59 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Poosti, L. di Malta, D. Gagne, N. Bernad, J.-C. Galleyrand, C. Escrieut, S. Silvente-Poirot, D. Fourmy, and J. Martinez The Third Intracellular Loop of the Rat and Mouse Cholecystokinin-A Receptors Is Responsible for Different Patterns of Gene Activation Mol. Pharmacol., April 13, 2001; 58(6): 1381 - 1388. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. J. Kim, B. M. Evers, D. A. Litvak, M. R. Hellmich, and C. M. Townsend Jr. Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA Am J Physiol Cell Physiol, August 1, 2000; 279(2): C326 - C334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dethloff, B. Barr, L. Bestervelt, S. Bulera, R. Sigler, M. LaGattuta, and F. de la Iglesia Gabapentin-Induced Mitogenic Activity in Rat Pancreatic Acinar Cells Toxicol. Sci., May 1, 2000; 55(1): 52 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Morisset, J. C. Aliaga, E. L. Calvo, J. Bourassa, and N. Rivard Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration Am J Physiol Gastrointest Liver Physiol, November 1, 1999; 277(5): G953 - G959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tapia, H. A. Ferris, R. T. Jensen, and L. J. Garcia Cholecystokinin Activates PYK2/CAKbeta by a Phospholipase C-dependent Mechanism and Its Association with the Mitogen-activated Protein Kinase Signaling Pathway in Pancreatic Acinar Cells J. Biol. Chem., October 29, 1999; 274(44): 31261 - 31271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bignon, A. Bachy, R. Boigegrain, R. Brodin, M. Cottineau, D. Gully, J.-M. Herbert, P. Keane, C. Labie, J.-C. Molimard, et al. SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. I: In Vitro Studies J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 742 - 751. [Abstract] [Full Text]
|
|
|
|
|
|
B. Nicke, M.-J. Tseng, M. Fenrich, and C. D. Logsdon Adenovirus-mediated gene transfer of RasN17 inhibits specific CCK actions on pancreatic acinar cells Am J Physiol Gastrointest Liver Physiol, February 1, 1999; 276(2): G499 - G506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schafer, S. E. Ross, M. J. Bragado, G. E. Groblewski, S. A. Ernst, and J. A. Williams A Role for the p38 Mitogen-activated Protein Kinase/Hsp 27 Pathway in Cholecystokinin-induced Changes in the Actin Cytoskeleton in Rat Pancreatic Acini J. Biol. Chem., September 11, 1998; 273(37): 24173 - 24180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dabrowski, JoyceA. VanderKuur, C. Carter-Su, and JohnA. Williams Cholecystokinin Stimulates Formation of Shc-Grb2 Complex in Rat Pancreatic Acinar Cells through a Protein Kinase C-dependent Mechanism J. Biol. Chem., October 25, 1996; 271(43): 27125 - 27129. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
